Bruce Kramer participated in a drug trial to determine if Dexpramipexole could slow the progression of ALS. Kramer felt the drug was working for him and was frustrated when the trial was terminated.
Bruce Kramer participated in a drug trial to determine if Dexpramipexole could slow the progression of ALS. Kramer felt the drug was working for him and was frustrated when the trial was terminated.